Neurotoxicity of Intrathecal Methotrexate: MR Imaging Findings

American Journal of Neuroradiology

Volumn 24, Issue 9, 2003, Pages 1887-1890

  Sandoval, Claudio ^a   Kutscher, Martin ^a   Jayabose, Somasundaram ^a   Tenner, Michael ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; DAUNORUBICIN; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APHASIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONFUSION; DIAGNOSTIC IMAGING; DIFFUSION; DRUG CYTOTOXICITY; EDEMA; FEMALE; HUMAN; IMAGE ANALYSIS; JAUNDICE; MUSCLE WEAKNESS; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PRE B LYMPHOCYTE; SYMPTOM;

ACUTE DISEASE; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN; BRAIN EDEMA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; METHOTREXATE; NEUROTOXICITY SYNDROMES;

EID: 0142135909     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Haskell CM, Rosen L. Antineoplastic agents. In: Haskell CM, ed. Cancer Treatment. 5th ed. Philadelphia: Saunders; 2001:176-181
2. Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. J Clin Oncol 1998;16:1712-1722
3. Lo Nigro L, Di Cataldo A, Schiliro G. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols. Med Pediatr Oncol 2000;35:449-455
4. Drachtman RA, Cole PD, Golden CB, et al. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol 2002;19:319-327
5. Quinn CT, Griener JC, Bottiglieri T, et al. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 1997;15:2800-2806
6. Davidson A, Payne G, Leach MO, et al. Proton magnetic resonance spectroscopy ([1]H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer. Med Pediatr Oncol 2000;35:28-34
7. Osterlundh G, Bjure J, Lannering B, et al. Studies of cerebral blood flow in children with acute lymphoblastic leukemia: case reports of six children treated with methotrexate examined by single photon emission computed tomography. J Pediatr Hematol Oncol 1997;19:28-34
8. Harila-Saari AH, Ahonen AK, Vainionpaa LK, et al. Brain perfusion after treatment of childhood acute lymphoblastic leukemia. J Nucl Med 1997;38:82-88
9. Karabacak NI, Ozturk G, Gucuyener K, et al. Assessment of brain perfusion by 99m Tc-HMPAO SPECT in akinetic mutism due to high-dose intravenous methotrexate therapy. Childs Nerv Syst 1997;13:560-562